Skip to main content
SpringerLink
Log in

New measles vaccine technologies show promise

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. GARRISON LP, Bauch CT, Bresnahan BW, Hazlet TK, Kadiyala S, Veenstra DL.A global cost-effectiveness evaluation of the impact of potential innovations in measles vaccination. 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research: 9 abstr. VA3, 16 May 2009. Available from: URL: http://www3.interscience.wiley.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

New measles vaccine technologies show promise. Pharmacoecon. Outcomes News 580, 4 (2009). https://doi.org/10.2165/00151234-200905800-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905800-00010

Keywords

Search

Navigation